71320-77-9 Category:
  • # LGM Pharma is a Moclobemide CAS# 71320-77-9 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Moclobemide
  • CAS #: 71320-77-9
  • Mode of Action:

    The mechanism of action of moclobemide involves the selective, reversible inhibition of MAO-A. This inhibition leads to a decrease in the metabolism and destruction of monoamines in the neurotransmitters. This results in an increase in the monoamines, relieving depressive symptoms.

  • Pharmacodynamics:

    Moclobemide belongs to a class of MAOI antidepressants known as reversible inhibitors of monoamine oxidase type-A (RIMAs). The primary role of monoamine oxidase MAO lies in the metabolism of and regulation of the levels of monoamines (serotonin, norepinephrine, and dopamine). Within neurons, MAO appears to regulate the levels of monoamines released upon synaptic firing. Since depression is associated with low levels of monoamines, the inhibition of MAO serves to ease depressive symptoms. RIMAs demonstrate transient inhibition of the substrate binding site of MAO-A as well as competitive displacement from this site by bioamines. The RIMAs are distinguished from the older monoamine oxidase inhibitors (MAOIs) by their selectivity and reversibility.

  • Metabolism:

    Moclobemide is almost completely metabolized in the liver by Cytochrome P450 2C19 and 2D6.

  • Toxicity:

    LD50 (mouse) is 730mg/kg and LD50 (rat) is 1, 300mg/kg. Signs of toxicity include hypertension, drowsiness, dizziness, confusion, tremors, headache, agitation, muscle rigidity and seizures.

  • IUPAC: 4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide
  • ATC: N06AG02
  • PubChem: 4235
  • DrugBank: DB01171 (APRD00603)
  • Formula: C17H27NO4
  • Molecular Mass: 268.739
  • Synonyms: 4-Chlor-N-(2-morpholinoethyl)benzamid 4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide 4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide Moclaime Moclamide Moclamine Moclobemid Moclobemida [INN-Spanish] Moclobemide [Usan:Ban:Inn] Moclobemidum [INN-Latin] p-Chloro-N-(2-morpholinoethyl)benzamide
  • AHFS Code: 28:16.04.12
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service